Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medtronic has received FDA approval to market the RestoreULTRA neurostimulation system for the treatment of chronic intractable pain of the trunk and limbs.
Subscribe to our email newsletter
The unique patient programmer used with the RestoreULTRA system gives patients more control over their therapy than ever before. In addition, the RestoreULTRA neurostimulator allows patients who use medium stimulation settings to go at least two weeks before needing to recharge. This rechargeable neurostimulator, is claimed to be the most advanced device in the market-leading Medtronic family of RESTORE devices.
Richard Kuntz, senior vice president of Medtronic, and president of the company’s Neuromodulation business, said: “We expect that the innovative features of the RestoreULTRA system will add an important therapy option for patients suffering from chronic pain.”